500 patients67,039 observations150 daysLIVE

Patient P-03292

Synthetic patientONX-7 · Day 108 · 25–34 · F · baseline S14Open companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
66%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S14
  2. Day 101 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 101.

Primary contributors, last 14 days
  • Toxicity+22
  • Nutritional resilience-14
  • GI instability+13
  • Inflammatory activity+5
  • Treatment adherence-5

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    62%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 84% showed improvement
    • median effect visible after 8 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 29/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Mucosal barrier integrity 50
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 52 and rising
    • Autonomic recovery 45
      • WearableResting HR 82 bpm
      • Wearable1,953 steps/day
    • Inflammatory signalling 40
      • BloodInflammatory load index 44
      • WearableHRV 31 ms, trending down
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2 · butyrate capacity 29/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    34 ms
    Sleep
    6.7 h
    Steps
    3,090
    Resting HR
    79 bpm
    Daily log: GI score 52, nutritional resilience 44, adherence 85.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0321852%S2056
    P-0312051%S1461
    P-0322149%S06GI-04no change64
    P-0337848%S1059
    P-0316046%S1863
    P-0334646%S17GI-04improved71
    P-0320042%S1659
    P-0337942%S12GI-04improved51
    P-0340542%S1662
    P-0302739%S2062
    P-0303139%S16CR-01improved49
    P-0324638%S1561